Artificial intelligence is becoming a core component in all aspects of diagnostics, drug discovery, and more, explains Nandha Balasubramaniam, Head of Digitalomics at Oracle Heath, who will be speaking at MD&M West.
FDA’s clearances are for artificial intelligence (AI) algorithms that detect leading indicators of heart disease.